CNY 15.82
(0.76%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 102.6 Million CNY | -49.45% |
2022 | 127.57 Million CNY | 2.3% |
2021 | 124.7 Million CNY | 5.94% |
2020 | 117.71 Million CNY | 6.32% |
2019 | 110.71 Million CNY | 3.41% |
2018 | 107.06 Million CNY | 21.89% |
2017 | 87.83 Million CNY | 336.51% |
2016 | 20.12 Million CNY | -56.75% |
2015 | 46.52 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 18.54 Million CNY | 61.6% |
2024 Q3 | 18.11 Million CNY | 59.85% |
2024 Q1 | 11.47 Million CNY | -26.69% |
2023 Q3 | 33.78 Million CNY | 55.0% |
2023 FY | 64.48 Million CNY | -49.45% |
2023 Q4 | 15.65 Million CNY | -53.66% |
2023 Q1 | 23.58 Million CNY | -15.09% |
2023 Q2 | 21.79 Million CNY | -7.6% |
2022 Q2 | 24.78 Million CNY | -14.82% |
2022 Q4 | 27.78 Million CNY | -39.49% |
2022 Q3 | 45.91 Million CNY | 85.24% |
2022 Q1 | 29.09 Million CNY | -5.0% |
2022 FY | 127.57 Million CNY | 2.3% |
2021 FY | 124.7 Million CNY | 5.94% |
2021 Q4 | 30.62 Million CNY | -26.81% |
2021 Q2 | 26.29 Million CNY | 1.37% |
2021 Q3 | 41.84 Million CNY | 59.18% |
2021 Q1 | 25.93 Million CNY | -8.05% |
2020 Q2 | 28.91 Million CNY | 42.02% |
2020 FY | 117.71 Million CNY | 6.32% |
2020 Q3 | 40.23 Million CNY | 39.14% |
2020 Q1 | 20.35 Million CNY | -31.08% |
2020 Q4 | 28.2 Million CNY | -29.89% |
2019 Q2 | 32.89 Million CNY | 105.01% |
2019 FY | 110.71 Million CNY | 3.41% |
2019 Q4 | 29.53 Million CNY | -8.36% |
2019 Q3 | 32.23 Million CNY | -2.02% |
2019 Q1 | 16.04 Million CNY | 0.0% |
2018 Q1 | 24.24 Million CNY | 0.0% |
2018 Q2 | 24.24 Million CNY | 0.0% |
2018 FY | 107.06 Million CNY | 21.89% |
2017 FY | 87.83 Million CNY | 336.51% |
2016 FY | 20.12 Million CNY | -56.75% |
2015 FY | 46.52 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Lifecome Biochemistry Co.,Ltd. | -236.13 Million CNY | 143.451% |
Chengdu Kanghua Biological Products Co., Ltd. | 576.61 Million CNY | 82.206% |
NanHua Bio-medicine Co., Ltd | -45.71 Million CNY | 324.442% |
Shandong Sito Bio-technology Co., Ltd. | 32.73 Million CNY | -213.395% |
Porton Pharma Solutions Ltd. | 268.91 Million CNY | 61.846% |
Zhejiang Wecome Pharmaceutical Company Limited | -1.01 Million CNY | 10223.565% |
Guangdong VTR Bio-Tech Co., Ltd. | 15.92 Million CNY | -544.402% |